International Clinical Trial: Risk Assessment, Prediction, and Clinical Strategy Development for Patients with Reproductive Immune Disorders

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119345) titled 'Risk Assessment, Prediction, and Clinical Strategy Development for Patients with Reproductive Immune Disorders' on Feb. 26.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)

Condition: Infertility Combined with Autoimmune Disorders

Intervention: Frozen embryo transfer:Frozen embryo transfer

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-01

Target Sample Size: Frozen embryo transfer:80;Fresh embyro transfer:80;

Countries of Recruitment: China

To know mo...